12-49051745-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003482.4(KMT2D):c.1938C>G(p.Pro646Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000985 in 136,058 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00098 ( 3 hom., cov: 28)
Exomes 𝑓: 0.0010 ( 30 hom. )
Failed GnomAD Quality Control
Consequence
KMT2D
NM_003482.4 synonymous
NM_003482.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.00
Publications
4 publications found
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 12-49051745-G-C is Benign according to our data. Variant chr12-49051745-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000985 (134/136058) while in subpopulation EAS AF = 0.0247 (110/4446). AF 95% confidence interval is 0.021. There are 3 homozygotes in GnomAd4. There are 63 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High AC in GnomAd4 at 134 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2D | NM_003482.4 | c.1938C>G | p.Pro646Pro | synonymous_variant | Exon 11 of 55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | c.1938C>G | p.Pro646Pro | synonymous_variant | Exon 11 of 55 | 5 | NM_003482.4 | ENSP00000301067.7 | ||
| KMT2D | ENST00000683543.2 | c.1938C>G | p.Pro646Pro | synonymous_variant | Exon 11 of 56 | ENSP00000506726.1 | ||||
| KMT2D | ENST00000685166.1 | c.1938C>G | p.Pro646Pro | synonymous_variant | Exon 10 of 54 | ENSP00000509386.1 | ||||
| KMT2D | ENST00000692637.1 | c.1938C>G | p.Pro646Pro | synonymous_variant | Exon 10 of 54 | ENSP00000509666.1 |
Frequencies
GnomAD3 genomes AF: 0.000993 AC: 135AN: 135952Hom.: 3 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
135
AN:
135952
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00186 AC: 457AN: 246138 AF XY: 0.00168 show subpopulations
GnomAD2 exomes
AF:
AC:
457
AN:
246138
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000998 AC: 1410AN: 1413366Hom.: 30 Cov.: 35 AF XY: 0.000938 AC XY: 660AN XY: 703816 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1410
AN:
1413366
Hom.:
Cov.:
35
AF XY:
AC XY:
660
AN XY:
703816
show subpopulations
African (AFR)
AF:
AC:
4
AN:
32468
American (AMR)
AF:
AC:
4
AN:
44252
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25372
East Asian (EAS)
AF:
AC:
1234
AN:
38808
South Asian (SAS)
AF:
AC:
22
AN:
85302
European-Finnish (FIN)
AF:
AC:
0
AN:
52726
Middle Eastern (MID)
AF:
AC:
1
AN:
5646
European-Non Finnish (NFE)
AF:
AC:
42
AN:
1070514
Other (OTH)
AF:
AC:
103
AN:
58278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.644
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000985 AC: 134AN: 136058Hom.: 3 Cov.: 28 AF XY: 0.000952 AC XY: 63AN XY: 66168 show subpopulations
GnomAD4 genome
AF:
AC:
134
AN:
136058
Hom.:
Cov.:
28
AF XY:
AC XY:
63
AN XY:
66168
show subpopulations
African (AFR)
AF:
AC:
12
AN:
36060
American (AMR)
AF:
AC:
0
AN:
13404
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3292
East Asian (EAS)
AF:
AC:
110
AN:
4446
South Asian (SAS)
AF:
AC:
6
AN:
4150
European-Finnish (FIN)
AF:
AC:
0
AN:
8788
Middle Eastern (MID)
AF:
AC:
0
AN:
204
European-Non Finnish (NFE)
AF:
AC:
5
AN:
63018
Other (OTH)
AF:
AC:
1
AN:
1880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.590
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jun 26, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Mar 11, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Kabuki syndrome 1 Benign:1
Aug 13, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Kabuki syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Nov 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.